Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations
Copenhagen (ots/PRNewswire) - Valcon Medical A/S ("Valcon Medical" or the "Company"), Denmark's leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021. Under the DKMA ...